Works by Tan, Ke


Results: 150
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    CircRNA–miRNA interactions in atherogenesis.

    Published in:
    Molecular & Cellular Biochemistry, 2022, v. 477, n. 12, p. 2703, doi. 10.1007/s11010-022-04455-8
    By:
    • Tong, Kind-Leng;
    • Tan, Ke-En;
    • Lim, Yat-Yuen;
    • Tien, Xin-Yi;
    • Wong, Pooi-Fong
    Publication type:
    Article
    46
    47
    48

    Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02285-w
    By:
    • Yang, Linyu;
    • Qiu, Qiang;
    • Wang, Jie;
    • Wen, Yi;
    • Li, He;
    • Liang, Rui;
    • Feng, Yunyu;
    • Wang, Fang;
    • Lin, Xiaojing;
    • Tang, Minghai;
    • Yang, Jianhong;
    • Pei, Heying;
    • Zhao, Peng;
    • Wang, Jishi;
    • Xiang, Jin;
    • Miao, Jia;
    • Zheng, Li;
    • Tan, Ke;
    • Wang, Yongsheng;
    • Hu, Yiguo
    Publication type:
    Article
    49
    50